The current study is aimed to investigate the relationship of plasma HMGB1 levels with body fat, glycolipid metabolism, insulin resistance (IR) and inflammation in obese adults and newly diagnosed T2DM patients. The gene discussed is HMGB1; the disease is Insulin resistance.